wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50091855-A1BBDB81-99FD-426F-82B2-176F10CC0588
Q50091855-A1BBDB81-99FD-426F-82B2-176F10CC0588
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50091855-A1BBDB81-99FD-426F-82B2-176F10CC0588
Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.
P2860
Q50091855-A1BBDB81-99FD-426F-82B2-176F10CC0588
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50091855-A1BBDB81-99FD-426F-82B2-176F10CC0588
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
618df5b4bc2f429cf2c5855b6c32d7c8a6587492
P2860
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.